Reuters: Nicotine Pouches Emerge as Big Tobacco’s Key Growth Bet
Nicotine pouches are gaining investor attention as cigarette sales decline, with brands like PMI's Zyn and BAT's Velo showing rapid growth and strong margins. BAT expects the global pouch market to grow from £4B in 2025 to £11B by 2030, with pouch volumes in Asia, Middle East, and Africa up 27.5% in H1 2026. PMI reported higher profitability for pouches compared to cigarettes and heated tobacco. Analysts note that pouch performance influences tobacco-company valuations, but wider adoption faces
How this was made
The 30-second read
Why it matters
Traders may use the disclosed growth and profitability comparisons to update relative expectations for tobacco companies’ smoke-free nicotine mix, but there is no single new company-specific catalyst like earnings, guidance, or a regulatory ruling.
Market read
Provides concrete pouch market growth and profitability framing that can influence tobacco valuation models, but lacks a fresh, tradable event trigger.
What to watch
Youth uptake scrutiny and marketing/high-nicotine-strength rules may drive product redesign, distribution limits, or slower adoption in key markets, reducing the speed of volume growth.
Background
The article frames nicotine pouches as a growth substitute for declining cigarette volumes, citing rapid category volume growth, strong margins, and lighter regulation in some markets.
Ticker impact
Reuters says PMI’s U.S. oral nicotine business generated eight times the gross profit per 1,000 units of its international cigarette business in 2024, highlighting pouch economics.
Moderate positive bias for PMI on any incremental pouch-demand or regulatory clarity headlines.
The article provides specific profitability comparisons and growth/margin framing, but it is still sector-level and not a new PMI-specific guidance or regulatory decision.
Market effects
Shifts investor focus from cigarettes to oral nicotine pouches, with valuation sensitivity to margins, volume growth, and regulatory trajectory.
Highlights uneven adoption and policy tightening in Europe (France ban; Finland/EU/Britain tightening), implying regional risk dispersion for pouch demand.
If pouch growth continues, it can re-rate large tobacco portfolios toward smoke-free nicotine, but adoption barriers and youth scrutiny remain global constraints.
Counterpoint
Regulatory tightening and lack of established oral-nicotine culture could cap category growth, making current margin/volume narratives less durable than investors assume.
Key entities
- companyPMI
Cited for U.S. oral nicotine gross-profit comparison versus international cigarettes and as a focus for pouch category performance.
- companyBAT
Cited for pouch market growth expectations and regional pouch volume growth in Asia, Middle East and Africa.
- productZyn
PMI brand referenced as a major pouch focus.
- productVelo
BAT brand referenced as a major pouch focus.
